These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 17868335
1. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand. Nonaka M, Tazuma S, Hyogo H, Kanno K, Chayama K. J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e198-206. PubMed ID: 17868335 [Abstract] [Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG. J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072 [Abstract] [Full Text] [Related]
9. Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Webster CR, Anwer MS. Hepatology; 2001 Mar 01; 33(3):608-15. PubMed ID: 11230741 [Abstract] [Full Text] [Related]
10. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. Liu W, Liang Q, Balzar S, Wenzel S, Gorska M, Alam R. J Allergy Clin Immunol; 2008 Apr 01; 121(4):893-902.e2. PubMed ID: 18395552 [Abstract] [Full Text] [Related]
11. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells. Zhu H, Pan X, Qi H, Wang X, Hou S, Han B, Liu Z, Xu L. Oncol Rep; 2011 Jan 01; 25(1):81-90. PubMed ID: 21109961 [Abstract] [Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines. Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF. Acta Pharmacol Sin; 2005 Jun 01; 26(6):753-61. PubMed ID: 15916743 [Abstract] [Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS, Chen WC, Bai X, Wang YD. J Dig Dis; 2007 May 01; 8(2):82-8. PubMed ID: 17532820 [Abstract] [Full Text] [Related]
15. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH. Cell Biol Int; 2008 Aug 01; 32(8):906-12. PubMed ID: 18474441 [Abstract] [Full Text] [Related]
16. Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells. Yu JH, Wang HJ, Li XR, Tashiro S, Onodera S, Ikejima T. Acta Pharmacol Sin; 2008 Sep 01; 29(9):1069-76. PubMed ID: 18718176 [Abstract] [Full Text] [Related]
17. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition. Matsumoto K, Okano J, Nagahara T, Murawaki Y. Int J Oncol; 2006 Dec 01; 29(6):1501-8. PubMed ID: 17088989 [Abstract] [Full Text] [Related]
18. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase. Takeuchi K, Shin-ya T, Nishio K, Ito F. FEBS J; 2009 Mar 01; 276(5):1255-65. PubMed ID: 19175673 [Abstract] [Full Text] [Related]
19. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM. J Pharmacol Exp Ther; 2009 Jun 01; 329(3):1063-70. PubMed ID: 19258520 [Abstract] [Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines. Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K. Cancer; 2002 Nov 15; 95(10):2243-51. PubMed ID: 12412180 [Abstract] [Full Text] [Related] Page: [Next] [New Search]